France
DIAFIR, founded in 2011, is a French innovator at the intersection of Biotechnology, Manufacturing, and Medical Devices. The company specializes in developing rapid, in situ biological analytical tools leveraging proprietary infra-red fiber sensor technology.
These groundbreaking systems have significant applications in POC medical diagnostics, food analysis, and monitoring organic chemical reactions. Notably, DIAFIR's technology can identify chronic liver disease, infections, or tumors in a swift five-minute process, positioning itself as a pivotal player in advancing medical diagnostics efficiency.
Recently, the company secured a substantial €800.00K Venture Round on May 19, 2021, funded by notable investors Go Capital and Happy Capital. This investment underscores the confidence and potential investors see in DIAFIR's innovative contributions to the healthcare sector. Based in France, the company is at the forefront of sensor technology, promising significant impact across its targeted industries.
